Ignite Creation Date:
2024-05-06 @ 10:49 AM
Last Modification Date:
2024-10-26 @ 12:36 PM
Study NCT ID:
NCT03361800
Status:
TERMINATED
Last Update Posted:
2024-03-25
First Post:
2017-11-28
Brief Title:
Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIICTNBC
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Organization:
UNC Lineberger Comprehensive Cancer Center
Organization Data
Organization:
UNC Lineberger Comprehensive Cancer Center
Class:
OTHER
Study ID:
LCCC 1639
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
UNC Lineberger Comprehensive Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Syndax Pharmaceuticals | INDUSTRY |
| National Cancer Institute NCI | NIH |